Ørsted (ORSTED) Guidance summary
Event summary combining transcript, slides, and related documents.
Guidance summary
4 Nov, 2026Opening remarks and agenda
Preliminary unaudited 2022 EBITDA was a record DKK 32.1bn including new partnerships, with DKK 11.0bn from the Hornsea 2 and Borkum Riffgrund 3 farm-downs; excluding partnerships, it was DKK 21.1bn, up from DKK 15.8bn in 2021, within latest guidance and above initial expectations.
Onshore and Bioenergy & Other outperformed expectations, while Offshore earnings declined amid adverse hedge effects and construction delays.
Guidance on key objectives
2023 EBITDA excluding new partnerships guided at DKK 20bn–23bn; the range widened from DKK 2bn to DKK 3bn due to higher energy-market volatility.
Generating offshore assets are expected to deliver earnings growth above 80%; Greater Changhua 1 and 2A commissioning is expected in H2, with higher Hornsea 2 generation, lower balancing costs and inflation-adjusted subsidies supporting earnings.
Onshore earnings are expected in line with 2022, as ramp-ups and Ostwind offset lower U.S. prices and Irish price caps; Bioenergy & Other is expected to fall significantly on normalized gas margins, lower volumes and lower CHP earnings.
Operational renewable asset earnings are expected to rise significantly; the 2027 offshore EBITDA ambition of DKK 35bn–40bn remains unchanged.
Market trends and strategic opportunities
2022 brought exceptional energy-price volatility, substantial inflation, rising interest rates and industry-wide offshore cost inflation.
Renewable policy support, including the U.S. Inflation Reduction Act and proposed European Net-Zero Industry Act, was cited as a market tailwind; European responses to the IRA were expected to support offshore wind and hydrogen.
IRA transferability is expected to ease ITC monetization; tax-credit partners and state stakeholders could improve U.S. project value, with stronger visibility targeted in H1 2023.
Q4 2022 wind speeds exceeded Q4 2021 levels but remained below normal; Onshore earnings benefited from generation ramp-up and higher achieved prices.
Latest events from Ørsted
- Adjusted EBITDA grew, but US impairments drove a Q3 loss as offshore projects advanced.ORSTED
Q3 2026 - Adjusted EBITDA beat guidance as the reset plan prioritizes value-led growth and balance-sheet resilience.ORSTED
Q4 2023 (Media) - Portfolio reset targets 35–38 GW of renewables by 2030 with tighter risk controls.ORSTED
Q4 2023 & Capital Markets Update - FY 2026 EBITDA guidance tops DKK 28bn as higher US rates raise impairment sensitivity.ORSTED
Pre-Close Call Presentation - H1 2026 EBITDA up, revenue rises 28%, profit drops on impairments; 2026 outlook reaffirmed.ORSTED
Q2 2026 - EBITDA set to exceed DKK 28 bn in 2026, with major divestments and improved ROCE outlook.ORSTED
Pre-Close Call Presentation - EBITDA to surpass DKK 28 bn in 2026, with major investments and US-driven impairments.ORSTED
Pre-Close Call Presentation - Key AGM resolutions passed; offshore wind strategy continued amid U.S. delays.ORSTED
AGM 2026 - Value-focused refocus, U.S. impairments and no FY2024 dividend; key AGM items approved.ORSTED
AGM 2025